Gyrus buys majority stake in Katalist Group

The company's management and founders have invested in the buyout alongside Gyrus, according to a statement.

A source familiar with the situation told Unquote that the proprietary deal came about via the development of a relationship with Katalist's founders, who were looking to take the next step in the company's growth.

The GP aims to make use of its experience in the food and pharmaceutical distribution field, acquiring and integrating further software companies to build up the group.

Gyrus Capital declined to comment.

Gyrus invests in businesses valued at EUR 50m-500m, specialising in corporate carve-outs and complex deals. The firm focuses on healthcare, sustainability and technology investments.

Katalist Group is the fourth deal from the GP's debut fund, which held a final close in August 2021 on EUR 430m, as reported. 

Click here to read a GP Profile of Gyrus Capital on Unquote.com.

Company
Katalist Group provides software implementation and consultancy services to food wholesalers and pharmacy companies. Its services aim to digitalise and optimise supply chains of perishable or sensitive goods and regulated medical products, according to the statement. It has operations in Europe (including Germany and Portugal), Asia, North and South America, employing more than 300 staff.

People
Gyrus Capital – Cédric Perlet (partner); Guy Semmens (managing partner).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Buyouts
• DACH
• Technology
• Gyrus Capital
• Germany